IP Library Granted Patent US 7,766,895
Granted Patent B2
US 7,766,895 · App. 11/104,717 · Granted Aug 3, 2010

Methods, systems, and kits for lung volume reduction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,766,895
App. No.
11/104,717
Granted
Aug 3, 2010
Kind
B2
Abstract

Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.

Claims (19)

1. A method for lung volume reduction, said method comprising:

introducing an access catheter to a patient's lungs;

isolating a lung tissue segment using the access catheter;

determining a disease-related parameter within the isolated segment using the access catheter,

introducing a sealing catheter to the patient's lungs; and

sealing an air passage which opens to the lung tissue segment using the sealing catheter.

2. A method as in claim 1 , wherein sealing comprises deploying a plug in the air passage.

3. A method as in claim 2 , wherein the plug is swellable and absorbs water to swell within the air passage when deployed.

4. A method as in claim 3 , wherein the plug comprises a collagen hydrogel which is not fully hydrated prior to deployment.

5. A method in claim 1 , wherein determining a disease-related parameter comprises measuring a compliance or pressure/volume curve of a lung tissue segment.

6. A method as in claim 1 , wherein determining a disease-related parameter comprises measuring air flow within the lung tissue segment.

7. A method as in claim 1 , wherein determining a disease-related parameter comprises measuring carbon dioxide concentration in the lung tissue segment.

8. A method as in claim 1 , wherein determining a disease-related parameter comprises measuring forced expiratory volume of the lung tissue segment.

9. A method as in claim 1 , wherein determining a disease-related parameter comprises measuring pressure within the lung tissue segment.

10. A method as in claim 1 , wherein isolating the lung tissue segment comprises positioning the access catheter in the air passage leading to the lung tissue segment and inflating an occlusion balloon on the access catheter to occlude the air passage.

11. A method as in claim 10 , further comprising drawing gas from the isolated lung segment through a lumen in the access catheter while the balloon remains inflated.

12. A method for lung volume reduction, said method comprising:

determining a disease-related parameter within an isolated segment using an access catheter; and

sealing an air passage which opens to a lung tissue segment using a sealing catheter.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2010
From: PERKINS, RODNEY A.; SOLTESZ, PETER P.; KOTMEL, ROBERT; WONDKA, ANTHONY D.
To: PULMONX
Reel/Frame 023865/0001 →